{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:20:41Z","timestamp":1743009641860,"version":"3.40.3"},"publisher-location":"Cham","reference-count":145,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319216829"},{"type":"electronic","value":"9783319216836"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-21683-6_39","type":"book-chapter","created":{"date-parts":[[2015,12,20]],"date-time":"2015-12-20T16:46:01Z","timestamp":1450629961000},"page":"829-866","source":"Crossref","is-referenced-by-count":0,"title":["Oncological Pain and Clinical Approaches"],"prefix":"10.1007","author":[{"given":"Daniel Humberto","family":"Pozza","sequence":"first","affiliation":[]},{"given":"Sara","family":"Gil-Mata","sequence":"additional","affiliation":[]},{"given":"Andreia Fontoura","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Turner","sequence":"additional","affiliation":[]},{"given":"Ramon Andrade","family":"de Mello","sequence":"additional","affiliation":[]},{"given":"Newton","family":"Barros","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"39_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437\u20131449","journal-title":"Ann Oncol"},{"key":"39_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0277-9536(99)00098-2","volume":"49","author":"D Clark","year":"1999","unstructured":"Clark D (1999) \u2018Total pain\u2019, disciplinary power and the body in the work of Cicely Saunders, 1958\u20131967. Soc Sci Med 49:727\u2013736","journal-title":"Soc Sci Med"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/0269216311400480","volume":"25","author":"KM Foley","year":"2011","unstructured":"Foley KM (2011) How well is cancer pain treated? Palliat Med 25:398\u2013401","journal-title":"Palliat Med"},{"key":"39_CR4","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985\u20131991","journal-title":"Ann Oncol"},{"key":"39_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/SPC.0b013e328336289c","volume":"4","author":"A Fairchild","year":"2010","unstructured":"Fairchild A (2010) Under-treatment of cancer pain. Curr Opin Support Palliat Care 4:11\u201315","journal-title":"Curr Opin Support Palliat Care"},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s101470200039","volume":"7","author":"RG Twycross","year":"2002","unstructured":"Twycross RG (2002) The challenge of palliative care. Int J Clin Oncol 7:271\u2013278","journal-title":"Int J Clin Oncol"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/mi.10.3.7","volume":"10","author":"BL Schmidt","year":"2010","unstructured":"Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL (2010) Mechanism of cancer pain. Mol Interv 10:164\u2013178","journal-title":"Mol Interv"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1073858414525828","volume":"20","author":"BL Schmidt","year":"2014","unstructured":"Schmidt BL (2014) The neurobiology of cancer pain. Neuroscientist 20:546\u2013562","journal-title":"Neuroscientist"},{"key":"39_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201\u2013209","journal-title":"Nat Rev Cancer"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nrn1914","volume":"7","author":"PW Mantyh","year":"2006","unstructured":"Mantyh PW (2006) Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7:797\u2013809","journal-title":"Nat Rev Neurosci"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJM199403033300902","volume":"330","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Gonin R, Hatfield AK et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592\u2013596","journal-title":"N Engl J Med"},{"key":"39_CR12","unstructured":"Swarm RA, Judith P, Anghelescu DL, Benedetti C, Cleeland C, deLeon-Casasola OA, et al (2014) Adult cancer pain. NCCN guidelines version 22014"},{"key":"39_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00002508-200409000-00008","volume":"20","author":"K Herr","year":"2004","unstructured":"Herr K, Titler MG, Schilling ML et al (2004) Evidence-based assessment of acute pain in older adults: current nursing practices and perceived barriers. Clin J Pain 20:331\u2013340","journal-title":"Clin J Pain"},{"key":"39_CR14","doi-asserted-by":"crossref","unstructured":"(1996) Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section. Anesthesiology 84:1243\u20131257","DOI":"10.1097\/00000542-199605000-00029"},{"issue":"Suppl 6","key":"39_CR15","doi-asserted-by":"crossref","first-page":"vi69","DOI":"10.1093\/annonc\/mdr390","volume":"22","author":"CI Ripamonti","year":"2011","unstructured":"Ripamonti CI, Bandieri E, Roila F (2011) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 22(Suppl 6):vi69\u2013vi77","journal-title":"Ann Oncol"},{"key":"39_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pmn.2006.06.005","volume":"7","author":"LJ Ware","year":"2006","unstructured":"Ware LJ, Epps CD, Herr K, Packard A (2006) Evaluation of the revised faces pain scale, verbal descriptor scale, numeric rating scale, and Iowa pain thermometer in older minority adults. Pain Manag Nurs 7:117\u2013125","journal-title":"Pain Manag Nurs"},{"key":"39_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","volume":"61","author":"RC Serlin","year":"1995","unstructured":"Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277\u2013284","journal-title":"Pain"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0304-3959(01)00314-1","volume":"93","author":"CL Hicks","year":"2001","unstructured":"Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B (2001) The faces pain scale-revised: toward a common metric in pediatric pain measurement. Pain 93:173\u2013183","journal-title":"Pain"},{"key":"39_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/AJP.0b013e31815ec22a","volume":"24","author":"JC Holen","year":"2008","unstructured":"Holen JC, Lydersen S, Klepstad P, Loge JH, Kaasa S (2008) The brief pain inventory: pain\u2019s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 24:219\u2013225","journal-title":"Clin J Pain"},{"key":"39_CR20","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 23:129\u2013138","journal-title":"Ann Acad Med Singap"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0304-3959(96)03131-4","volume":"67","author":"CS Cleeland","year":"1996","unstructured":"Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC (1996) Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 67:267\u2013273","journal-title":"Pain"},{"key":"39_CR22","doi-asserted-by":"crossref","unstructured":"Picot T, Hamid B (2010) Decision-making in the cancer pain setting: beyond the WHO ladder. Tech Reg Anesth Pain Manag 14:19\u201324","DOI":"10.1053\/j.trap.2009.12.003"},{"key":"39_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1526-4637.2010.00840.x","volume":"11","author":"J Raphael","year":"2010","unstructured":"Raphael J, Ahmedzai S, Hester J et al (2010) Cancer pain: part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11:742\u2013764","journal-title":"Pain Med"},{"key":"39_CR24","unstructured":"World Health Organization (1990) Cancer pain relief and palliative care, Geneva, WHO Technical Report Series, No. 804"},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpainsymman.2004.08.004","volume":"29","author":"M Meldrum","year":"2005","unstructured":"Meldrum M (2005) The ladder and the clock: cancer pain and public policy at the end of the twentieth century. J Pain Symptom Manag 29:41\u201354","journal-title":"J Pain Symptom Manag"},{"key":"39_CR26","volume-title":"British national formulary","author":"Committee JF","year":"2007","unstructured":"Committee JF (2007) British national formulary, 55th edn. British Medical Association and Royal Pharmaceutical Society of Great Britain, London","edition":"55"},{"key":"39_CR27","volume-title":"Control of pain in adults with cancer. A national clinical guideline","author":"Network. SIG","year":"2008","unstructured":"Network. SIG (2008) Control of pain in adults with cancer. A national clinical guideline. NHS, Edinburgh"},{"key":"39_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1049909106295431","volume":"24","author":"SL Mercadante","year":"2007","unstructured":"Mercadante SL, Berchovich M, Casuccio A, Fulfaro F, Mangione S (2007) A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care 24:13\u201319","journal-title":"Am J Hosp Palliat Care"},{"key":"39_CR29","unstructured":"Administratition USFaD (2013) Transmucosal Immediate Release of Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS). Silver Spring"},{"key":"39_CR30","unstructured":"Administratition USFaD (2013) Extended Release (ER) and Long-Acting (LA) Opioid analgesics Risk Evaluation and Mitigation Strategy (REMS). Silver Spring"},{"key":"39_CR31","first-page":"1499","volume":"18","author":"NI Cherny","year":"2004","unstructured":"Cherny NI (2004) The pharmacologic management of cancer pain. Oncology (Williston Park) 18:1499\u20131515; discussion 516, 520\u2013521, 522, 524","journal-title":"Oncology (Williston Park)"},{"key":"39_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2165\/11597260-000000000-00000","volume":"72","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Pharmacotherapy for breakthrough cancer pain. Drugs 72:181\u2013190","journal-title":"Drugs"},{"key":"39_CR33","first-page":"Cd004311","volume":"10","author":"G Zeppetella","year":"2013","unstructured":"Zeppetella G, Davies AN (2013) Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev 10:Cd004311","journal-title":"Cochrane Database Syst Rev"},{"key":"39_CR34","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1001\/jama.290.18.2476","volume":"290","author":"E Bruera","year":"2003","unstructured":"Bruera E, Kim HN (2003) Cancer pain. JAMA 290:2476\u20132479","journal-title":"JAMA"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/107327480000700203","volume":"7","author":"RA Stevens","year":"2000","unstructured":"Stevens RA, Ghazi SM (2000) Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 7:132\u2013141","journal-title":"Cancer Control"},{"key":"39_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1191\/0269216303pm695oa","volume":"17","author":"JT Harris","year":"2003","unstructured":"Harris JT, Suresh Kumar K, Rajagopal MR (2003) Intravenous morphine for rapid control of severe cancer pain. Palliat Med 17:248\u2013256","journal-title":"Palliat Med"},{"key":"39_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","volume":"80","author":"TF Meert","year":"2005","unstructured":"Meert TF, Vermeirsch HA (2005) A preclinical comparison between different opioids: antinociceptive versus adverse effects. Pharmacol Biochem Behav 80:309\u2013326","journal-title":"Pharmacol Biochem Behav"},{"key":"39_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/bmj.326.7390.635","volume":"326","author":"A Holdcroft","year":"2003","unstructured":"Holdcroft A, Power I (2003) Recent developments: management of pain. BMJ 326:635\u2013639","journal-title":"BMJ"},{"key":"39_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/clpt.1990.85","volume":"47","author":"E Kalso","year":"1990","unstructured":"Kalso E, Vainio A (1990) Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 47:639\u2013646","journal-title":"Clin Pharmacol Ther"},{"key":"39_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0304-3959(94)00148-8","volume":"61","author":"PJ Tiseo","year":"1995","unstructured":"Tiseo PJ, Thaler HT, Lapin J, Inturrisi CE, Portenoy RK, Foley KM (1995) Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain 61:47\u201354","journal-title":"Pain"},{"key":"39_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3959(91)90005-I","volume":"47","author":"RK Portenoy","year":"1991","unstructured":"Portenoy RK, Foley KM, Stulman J et al (1991) Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure. Pain 47:13\u201319","journal-title":"Pain"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","volume":"11","author":"AM Trescot","year":"2008","unstructured":"Trescot AM, Datta S, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician 11:S133\u2013S153","journal-title":"Pain Physician"},{"key":"39_CR43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587\u2013593","journal-title":"Br J Cancer"},{"key":"39_CR44","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","volume":"29","author":"A Murray","year":"2005","unstructured":"Murray A, Hagen NA (2005) Hydromorphone. J Pain Symptom Manag 29:S57\u2013S66","journal-title":"J Pain Symptom Manag"},{"key":"39_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/jpm.2004.7.545","volume":"7","author":"D Thwaites","year":"2004","unstructured":"Thwaites D, McCann S, Broderick P (2004) Hydromorphone neuroexcitation. J Palliat Med 7:545\u2013550","journal-title":"J Palliat Med"},{"key":"39_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","volume":"69","author":"AW Wright","year":"2001","unstructured":"Wright AW, Mather LE, Smith MT (2001) Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 69:409\u2013420","journal-title":"Life Sci"},{"key":"39_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1185\/030079904125003854","volume":"20","author":"NY Gabrail","year":"2004","unstructured":"Gabrail NY, Dvergsten C, Ahdieh H (2004) Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 20:911\u2013918","journal-title":"Curr Med Res Opin"},{"key":"39_CR48","doi-asserted-by":"crossref","unstructured":"Trescot AM, DS, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician 11(2 Suppl):S133\u201353","DOI":"10.36076\/ppj.2008\/11\/S133"},{"key":"39_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s005200000222","volume":"9","author":"MP Davis","year":"2001","unstructured":"Davis MP, Homsi J (2001) The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine. Support Care Cancer 9:442\u2013451","journal-title":"Support Care Cancer"},{"key":"39_CR50","doi-asserted-by":"crossref","unstructured":"Nicholson AB (2004) Methadone for cancer pain. Cochrane Database Syst Rev 17; (4):CD003971.","DOI":"10.1002\/14651858.CD003971.pub2"},{"key":"39_CR51","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/jpm.2012.0612","volume":"16","author":"SR Salpeter","year":"2013","unstructured":"Salpeter SR, Buckley JS, Bruera E (2013) The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med 16:616\u2013622","journal-title":"J Palliat Med"},{"key":"39_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","volume":"137","author":"MJ Krantz","year":"2002","unstructured":"Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS (2002) Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 137:501\u2013504","journal-title":"Ann Intern Med"},{"key":"39_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","volume":"105","author":"CA Kornick","year":"2003","unstructured":"Kornick CA, Kilborn MJ, Santiago-Palma J et al (2003) QTc interval prolongation associated with intravenous methadone. Pain 105:499\u2013506","journal-title":"Pain"},{"key":"39_CR54","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","volume":"23","author":"MJ Krantz","year":"2003","unstructured":"Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS (2003) Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 23:802\u2013805","journal-title":"Pharmacotherapy"},{"key":"39_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/jpm.2006.0201","volume":"10","author":"JP McNulty","year":"2007","unstructured":"McNulty JP (2007) Can levorphanol be used like methadone for intractable refractory pain? J Palliat Med 10:293\u2013296","journal-title":"J Palliat Med"},{"key":"39_CR56","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.clinthera.2013.09.008","volume":"35","author":"TJ Atkinson","year":"2013","unstructured":"Atkinson TJ, Fudin J, Pandula A, Mirza M (2013) Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther 35:1669\u20131689","journal-title":"Clin Ther"},{"key":"39_CR57","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMoa021420","volume":"348","author":"MC Rowbotham","year":"2003","unstructured":"Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348:1223\u20131232","journal-title":"N Engl J Med"},{"key":"39_CR58","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","volume":"43","author":"S Grond","year":"2004","unstructured":"Grond S, Sablotzki A (2004) Clinical pharmacology of tramadol. Clin Pharmacokinet 43:879\u2013923","journal-title":"Clin Pharmacokinet"},{"key":"39_CR59","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0885-3924(99)00060-3","volume":"18","author":"S Grond","year":"1999","unstructured":"Grond S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann KA (1999) High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manag 18:174\u2013179","journal-title":"J Pain Symptom Manag"},{"key":"39_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/jpm.2006.0117","volume":"10","author":"RF Rodriguez","year":"2007","unstructured":"Rodriguez RF, Bravo LE, Castro F et al (2007) Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. J Palliat Med 10:56\u201360","journal-title":"J Palliat Med"},{"key":"39_CR61","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1185\/03007995.2012.739151","volume":"28","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, Porzio G, Ferrera P et al (2012) Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin 28:1775\u20131779","journal-title":"Curr Med Res Opin"},{"key":"39_CR62","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00432-013-1487-0","volume":"139","author":"C Naing","year":"2013","unstructured":"Naing C, Aung K, Racloz V, Yeoh PN (2013) Safety and efficacy of transdermal buprenorphine for the relief of cancer pain. J Cancer Res Clin Oncol 139:1963\u20131970","journal-title":"J Cancer Res Clin Oncol"},{"key":"39_CR63","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1185\/03007990902920731","volume":"25","author":"JV Pergolizzi Jr","year":"2009","unstructured":"Pergolizzi JV Jr, Mercadante S, Echaburu AV et al (2009) The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Curr Med Res Opin 25:1517\u20131528","journal-title":"Curr Med Res Opin"},{"key":"39_CR64","first-page":"707","volume":"5","author":"S Deandrea","year":"2009","unstructured":"Deandrea S, Corli O, Moschetti I, Apolone G (2009) Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review. Ther Clin Risk Manag 5:707\u2013718","journal-title":"Ther Clin Risk Manag"},{"key":"39_CR65","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","volume":"32","author":"S Mercadante","year":"2006","unstructured":"Mercadante S, Bruera E (2006) Opioid switching: a systematic and critical review. Cancer Treat Rev 32:304\u2013315","journal-title":"Cancer Treat Rev"},{"key":"39_CR66","unstructured":"Society AP (2003) Principles of analgesic use in the treatment of acute pain and cancer pain. Glenview"},{"key":"39_CR67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.clon.2011.04.003","volume":"23","author":"JG de Courcy","year":"2011","unstructured":"de Courcy JG (2011) Interventional techniques for cancer pain management. Clin Oncol (R Coll Radiol) 23:407\u2013417","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"39_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0885-3924(02)00682-6","volume":"25","author":"KO Anderson","year":"2003","unstructured":"Anderson KO, Getto CJ, Mendoza TR et al (2003) Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manag 25:307\u2013318","journal-title":"J Pain Symptom Manag"},{"key":"39_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00435383","volume":"3","author":"RK Portenoy","year":"1994","unstructured":"Portenoy RK, Thaler HT, Kornblith AB et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183\u2013189","journal-title":"Qual Life Res"},{"key":"39_CR70","unstructured":"(2005) Recommandations pour la pratique clinique 2005: Standards, Options et Recommandations pour la prise en charge des douleurs provoqu\u00e9es lors des ponctions lombaires, osseuses et sanguines chez l\u2019adulte atteint de cancer 92"},{"key":"39_CR71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1365-2648.1999.00903.x","volume":"29","author":"M de Rond","year":"1999","unstructured":"de Rond M, de Wit R, van Dam F et al (1999) Daily pain assessment: value for nurses and patients. J Adv Nurs 29:436\u2013444","journal-title":"J Adv Nurs"},{"key":"39_CR72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/109662101750290227","volume":"4","author":"P Allard","year":"2001","unstructured":"Allard P, Maunsell E, Labbe J, Dorval M (2001) Educational interventions to improve cancer pain control: a systematic review. J Palliat Med 4:191\u2013203","journal-title":"J Palliat Med"},{"key":"39_CR73","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S et al (2008) Opioid complications and side effects. Pain Physician 11:S105\u2013S120","journal-title":"Pain Physician"},{"key":"39_CR74","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.6004\/jnccn.2010.0076","volume":"8","author":"R Swarm","year":"2010","unstructured":"Swarm R, Abernethy AP, Anghelescu DL et al (2010) Adult cancer pain. J Natl Compr Cancer Netw 8:1046\u20131086","journal-title":"J Natl Compr Cancer Netw"},{"key":"39_CR75","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58\u2013e68","journal-title":"Lancet Oncol"},{"key":"39_CR76","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bpa.2013.10.007","volume":"27","author":"K Auret","year":"2013","unstructured":"Auret K, Schug SA (2013) Pain management for the cancer patient \u2013 current practice and future developments. Best Pract Res Clin Anaesthesiol 27:545\u2013561","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"39_CR77","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2230.2009.03463.x","volume":"35","author":"A Reich","year":"2010","unstructured":"Reich A, Szepietowski JC (2010) Opioid-induced pruritus: an update. Clin Exp Dermatol 35:2\u20136","journal-title":"Clin Exp Dermatol"},{"key":"39_CR78","first-page":"S105","volume":"11","author":"M Ricardo Buenaventura","year":"2008","unstructured":"Ricardo Buenaventura M, Rajive Adlaka M, Nalini SM (2008) Opioid complications and side effects. Pain Physician 11:S105\u2013S120","journal-title":"Pain Physician"},{"key":"39_CR79","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2174\/138161211796197070","volume":"17","author":"M Zutler","year":"2011","unstructured":"Zutler M, Holty JE (2011) Opioids, sleep, and sleep-disordered breathing. Curr Pharm Des 17:1443\u20131449","journal-title":"Curr Pharm Des"},{"key":"39_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/00002018-200831050-00002","volume":"31","author":"KM Verhamme","year":"2008","unstructured":"Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R (2008) Drug-induced urinary retention: incidence, management and prevention. Drug Saf 31:373\u2013388","journal-title":"Drug Saf"},{"key":"39_CR81","doi-asserted-by":"crossref","unstructured":"De Maddalena C, Bellini M, Berra M, Meriggiola MC, Aloisi AM (2012) Opioid-induced hypogonadism: why and how to treat it. Pain Physician 15; 15(3 Suppl):ES111-8.","DOI":"10.36076\/ppj.2012\/15\/ES111"},{"key":"39_CR82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14:145\u2013161","journal-title":"Pain Physician"},{"key":"39_CR83","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pmn.2007.02.004","volume":"8","author":"A DuPen","year":"2007","unstructured":"DuPen A, Shen D, Ersek M (2007) Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 8:113\u2013121","journal-title":"Pain Manag Nurs"},{"key":"39_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1191\/0269216304pm879oa","volume":"18","author":"C Centeno","year":"2004","unstructured":"Centeno C, Sanz \u00c1, Bruera E (2004) Delirium in advanced cancer patients. Palliat Med 18:184\u2013194","journal-title":"Palliat Med"},{"key":"39_CR85","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/cncr.22665","volume":"109","author":"JD Gaudreau","year":"2007","unstructured":"Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A (2007) Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 109:2365\u20132373","journal-title":"Cancer"},{"key":"39_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7861\/clinmedicine.13-2-149","volume":"13","author":"J Boland","year":"2013","unstructured":"Boland J, Boland E, Brooks D (2013) Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone. Clin Med 13:149\u2013151","journal-title":"Clin Med"},{"key":"39_CR87","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","volume":"112","author":"A Dahan","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW (2010) Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 112:226\u2013238","journal-title":"Anesthesiology"},{"key":"39_CR88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G et al (2013) Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65:223\u2013254","journal-title":"Pharmacol Rev"},{"key":"39_CR89","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1526-4637.2012.01357.x","volume":"13","author":"LR Webster","year":"2012","unstructured":"Webster LR, Fine PG (2012) Review and critique of opioid rotation practices and associated risks of toxicity. Pain Med 13:562\u2013570","journal-title":"Pain Med"},{"key":"39_CR90","unstructured":"Food and Drugs Administration (2012) Extended Release (ER) and Long-Acting (LA) Opioid analgesics Risk Evaluation and Mitigation Strategy (REMS) USA"},{"key":"39_CR91","doi-asserted-by":"crossref","unstructured":"McNicol E, Strassels S, Goudas L, Lau J, Carr DB (2005) NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 1","DOI":"10.1002\/14651858.CD005180"},{"key":"39_CR92","doi-asserted-by":"crossref","unstructured":"Vardy J, Agar M (2014) Nonopioid drugs in the treatment of cancer pain. J Clin Oncol 32(16):1677\u20131690","DOI":"10.1200\/JCO.2013.52.8356"},{"key":"39_CR93","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","volume":"23","author":"T Middlemiss","year":"2011","unstructured":"Middlemiss T, Laird BJA, Fallon MT (2011) Mechanisms of cancer-induced bone pain. Clin Oncol 23:387\u2013392","journal-title":"Clin Oncol"},{"key":"39_CR94","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","volume":"154","author":"P Mantyh","year":"2013","unstructured":"Mantyh P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. PAIN\u00ae 154:S54\u2013S62","journal-title":"PAIN\u00ae"},{"key":"39_CR95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","volume":"24","author":"E Chow","year":"2012","unstructured":"Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S (2012) Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol 24:112\u2013124","journal-title":"Clin Oncol"},{"key":"39_CR96","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","volume":"25","author":"E Chow","year":"2007","unstructured":"Chow E, Harris K, Fan G, Tsao M, Sze WM (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423\u20131436","journal-title":"J Clin Oncol"},{"key":"39_CR97","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/sj.bjc.6601663","volume":"90","author":"JJ Body","year":"2004","unstructured":"Body JJ, Diel IJ, Lichinitzer M et al (2004) Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. Br J Cancer 90:1133\u20131137","journal-title":"Br J Cancer"},{"key":"39_CR98","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pain.2004.07.011","volume":"111","author":"JJ Body","year":"2004","unstructured":"Body JJ, Diel IJ, Bell R et al (2004) Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain 111:306\u2013312","journal-title":"Pain"},{"key":"39_CR99","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cncr.27789","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Body JJ, Stopeck A et al (2013) Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119:832\u2013838","journal-title":"Cancer"},{"key":"39_CR100","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/sj.bjc.6602551","volume":"92","author":"A Wardley","year":"2005","unstructured":"Wardley A, Davidson N, Barrett-Lee P et al (2005) Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br J Cancer 92:1869\u20131876","journal-title":"Br J Cancer"},{"key":"39_CR101","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/annonc\/mds175","volume":"23","author":"S Vadhan-Raj","year":"2012","unstructured":"Vadhan-Raj S, von Moos R, Fallowfield LJ et al (2012) Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol 23:3045\u20133051","journal-title":"Ann Oncol"},{"key":"39_CR102","first-page":"7343","volume":"62","author":"MAC Sabino","year":"2002","unstructured":"Sabino MAC, Ghilardi JR, Jongen JL et al (2002) Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 62:7343\u20137349","journal-title":"Cancer Res"},{"key":"39_CR103","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.2009-S505","volume":"15","author":"MJ Lema","year":"2010","unstructured":"Lema MJ, Foley KM, Hausheer FH (2010) Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. Oncologist 15:3\u20138","journal-title":"Oncologist"},{"key":"39_CR104","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/0269216312464408","volume":"27","author":"C Rayment","year":"2013","unstructured":"Rayment C, Hjermstad MJ, Aass N et al (2013) Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative\u2013Computerised Symptom Assessment study. Palliat Med 27:714\u2013721","journal-title":"Palliat Med"},{"key":"39_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0304-3959(98)00138-9","volume":"79","author":"S Grond","year":"1999","unstructured":"Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA (1999) Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79:15\u201320","journal-title":"Pain"},{"key":"39_CR106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aet208","volume":"111","author":"MT Fallon","year":"2013","unstructured":"Fallon MT (2013) Neuropathic pain in cancer. Br J Anaesth 111:105\u2013111","journal-title":"Br J Anaesth"},{"key":"39_CR107","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.nurt.2009.07.002","volume":"6","author":"K Arning","year":"2009","unstructured":"Arning K, Baron R (2009) Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions. Neurotherapeutics 6:738\u2013748","journal-title":"Neurotherapeutics"},{"key":"39_CR108","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:807\u2013819","journal-title":"Lancet Neurol"},{"key":"39_CR109","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","volume":"10","author":"J Scholz","year":"2007","unstructured":"Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361\u20131368","journal-title":"Nat Neurosci"},{"key":"39_CR110","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002","volume":"22","author":"KA Moore","year":"2002","unstructured":"Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22:6724\u20136731","journal-title":"J Neurosci"},{"key":"39_CR111","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ALN.0b013e31825adb2b","volume":"117","author":"SN Raja","year":"2012","unstructured":"Raja SN, Treede R-D (2012) Testing the link between sympathetic efferent and sensory afferent fibers in neuropathic pain. Anesthesiology 117:173","journal-title":"Anesthesiology"},{"key":"39_CR112","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","volume":"11","author":"M Calvo","year":"2012","unstructured":"Calvo M, Dawes JM, Bennett DLH (2012) The role of the immune system in the generation of neuropathic pain. Lancet Neurol 11:629\u2013642","journal-title":"Lancet Neurol"},{"key":"39_CR113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1533-2500.2011.00485.x","volume":"12","author":"A Vadalouca","year":"2012","unstructured":"Vadalouca A, Raptis E, Moka E, Zis P, Sykioti P, Siafaka I (2012) Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract 12:219\u2013251","journal-title":"Pain Pract"},{"key":"39_CR114","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ (2006) The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6:108\u2013113","journal-title":"Curr Opin Pharmacol"},{"key":"39_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pain.2008.11.019","volume":"142","author":"CP Taylor","year":"2009","unstructured":"Taylor CP (2009) Mechanisms of analgesia by gabapentin and pregabalin \u2013 calcium channel \u03b12-\u03b4 [Cav\u03b12-\u03b4] ligands. Pain 142:13\u201316","journal-title":"Pain"},{"key":"39_CR116","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1002\/cncr.25274","volume":"116","author":"V Bar Ad","year":"2010","unstructured":"Bar Ad V, Weinstein G, Dutta PR et al (2010) Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy. Cancer 116:4206\u20134213","journal-title":"Cancer"},{"key":"39_CR117","doi-asserted-by":"crossref","unstructured":"Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev:7;(4):CD005454","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"39_CR118","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","volume":"96","author":"SH Sindrup","year":"2005","unstructured":"Sindrup SH, Otto M, Finnerup NB, Jensen TS (2005) Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96:399\u2013409","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"39_CR119","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","volume":"28","author":"K Sideras","year":"2010","unstructured":"Sideras K, Ingle JN, Ames MM et al (2010) Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol 28:2768\u20132776","journal-title":"J Clin Oncol"},{"key":"39_CR120","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","volume":"59","author":"SN Raja","year":"2002","unstructured":"Raja SN, Haythornthwaite JA, Pappagallo M et al (2002) Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59:1015\u20131021","journal-title":"Neurology"},{"key":"39_CR121","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ejca.2008.02.028","volume":"44","author":"CI Ripamonti","year":"2008","unstructured":"Ripamonti CI, Easson AM, Gerdes H (2008) Management of malignant bowel obstruction. Eur J Cancer 44:1105\u20131115","journal-title":"Eur J Cancer"},{"key":"39_CR122","doi-asserted-by":"publisher","first-page":"vii139","DOI":"10.1093\/annonc\/mds233","volume":"23","author":"CI Ripamonti","year":"2012","unstructured":"Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F, Group obotEGW (2012) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 23:vii139\u2013vii154","journal-title":"Ann Oncol"},{"key":"39_CR123","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.clon.2011.04.003","volume":"23","author":"JG de Courcy","year":"2011","unstructured":"de Courcy JG (2011) Interventional techniques for cancer pain management. Clin Oncol 23:407\u2013417","journal-title":"Clin Oncol"},{"key":"39_CR124","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0885-3924(93)90195-2","volume":"8","author":"DP Myers","year":"1993","unstructured":"Myers DP, Lema MJ, De Leon-Casasola OA, Bacon DR (1993) Interpleural analgesia for the treatment of severe cancer pain in terminally ill patients. J Pain Symptom Manag 8:505\u2013510","journal-title":"J Pain Symptom Manag"},{"key":"39_CR125","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1191\/026921699670764204","volume":"13","author":"B Amesbury","year":"1999","unstructured":"Amesbury B, O\u2019Riordan J, Dolin S (1999) The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med 13:153\u2013158","journal-title":"Palliat Med"},{"key":"39_CR126","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-4614-1560-2_38","volume-title":"Intrapleural catheters. Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches","author":"KE Vorenkamp","year":"2013","unstructured":"Vorenkamp KE, Kohan LR (2013) Intrapleural catheters. Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches. Springer, New York, pp 393\u2013402"},{"key":"39_CR127","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/bja\/aen105","volume":"101","author":"W Chambers","year":"2008","unstructured":"Chambers W (2008) Nerve blocks in palliative care. Br J Anaesth 101:95\u2013100","journal-title":"Br J Anaesth"},{"key":"39_CR128","doi-asserted-by":"crossref","unstructured":"Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (2011) Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 3","DOI":"10.1002\/14651858.CD007519.pub2"},{"key":"39_CR129","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/papr.12083","volume":"14","author":"W Zhong","year":"2014","unstructured":"Zhong W, Yu Z, Zeng JX et al (2014) Celiac plexus block for treatment of pain associated with pancreatic cancer: a meta analysis. Pain Pract 14:43\u201351","journal-title":"Pain Pract"},{"key":"39_CR130","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1148\/rg.316115526","volume":"31","author":"A Kambadakone","year":"2011","unstructured":"Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS (2011) CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 31:1599\u20131621","journal-title":"Radiographics"},{"key":"39_CR131","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/014107689308600507","volume":"86","author":"DD Davies","year":"1993","unstructured":"Davies DD (1993) Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 86:264\u2013266","journal-title":"J R Soc Med"},{"key":"39_CR132","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0310057X0803600518","volume":"36","author":"S Mishra","year":"2008","unstructured":"Mishra S, Bhatnagar S, Gupta D, Thulkar S (2008) Anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain. Anaesth Intensive Care 36:732","journal-title":"Anaesth Intensive Care"},{"key":"39_CR133","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/01.ajp.0000202978.06045.24","volume":"22","author":"G Gamal","year":"2006","unstructured":"Gamal G, Helaly M, Labib YM (2006) Superior hypogastric block: transdiscal versus classic posterior approach in pelvic cancer pain. Clin J Pain 22:544\u2013547","journal-title":"Clin J Pain"},{"key":"39_CR134","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/AJP.0b013e3181dedfa9","volume":"26","author":"D Nabil","year":"2010","unstructured":"Nabil D, Eissa AA (2010) Evaluation of posteromedial transdiscal superior hypogastric block after failure of the classic approach. Clin J Pain 26:694\u2013697","journal-title":"Clin J Pain"},{"key":"39_CR135","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.trap.2009.10.001","volume":"14","author":"WD Mauck","year":"2010","unstructured":"Mauck WD, Rho RH (2010) The role of neurolytic sympathetic blocks in treating cancer pain. Tech Reg Anesth Pain Manag 14:32\u201339","journal-title":"Tech Reg Anesth Pain Manag"},{"key":"39_CR136","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/pme.12065","volume":"14","author":"A Khosla","year":"2013","unstructured":"Khosla A, Adeyefa O, Nasir S (2013) Successful treatment of radiation-induced proctitis pain by blockade of the ganglion impar in an elderly patient with prostate cancer: a case report. Pain Med 14:662\u2013666","journal-title":"Pain Med"},{"key":"39_CR137","first-page":"63","volume":"5","author":"E Rabah","year":"2001","unstructured":"Rabah E, Souyet H, Aguilera C, Elzo JJ (2001) Neurolytic block of the ganglion impar (Walther) in chronic radiation proctitis. Analgesia 5:63\u201365","journal-title":"Analgesia"},{"key":"39_CR138","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/AJP.0b013e3181a5f5c7","volume":"25","author":"K Agarwal-Kozlowski","year":"2009","unstructured":"Agarwal-Kozlowski K, Lorke DE, Habermann CR, Am Esch JS, Beck H (2009) CT-guided blocks and neuroablation of the ganglion impar (Walther) in perineal pain: anatomy, technique, safety, and efficacy. Clin J Pain 25:570\u2013576","journal-title":"Clin J Pain"},{"key":"39_CR139","doi-asserted-by":"crossref","unstructured":"Amr YM, Makharita MY Neurolytic sympathectomy in the management of cancer pain\u2014time effect: a prospective, randomized multicenter study. J Pain Symptom Manag 48(5):944\u201356.e2","DOI":"10.1016\/j.jpainsymman.2014.01.015"},{"key":"39_CR140","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1526-4637.2004.04037.x","volume":"5","author":"AW Burton","year":"2004","unstructured":"Burton AW, Rajagopal A, Shah HN et al (2004) Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 5:239\u2013247","journal-title":"Pain Med"},{"key":"39_CR141","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11916-007-0205-5","volume":"11","author":"PA Sloan","year":"2007","unstructured":"Sloan PA (2007) Neuraxial pain relief for intractable cancer pain. Curr Pain Headache Rep 11:283\u2013289","journal-title":"Curr Pain Headache Rep"},{"key":"39_CR142","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12630-013-0075-8","volume":"61","author":"CE Smyth","year":"2014","unstructured":"Smyth CE, Jarvis V, Poulin P (2014) Brief review: neuraxial analgesia in refractory malignant pain. Can J Anesth J Can d\u2019Anesth 61:141\u2013153","journal-title":"Can J Anesth J Can d\u2019Anesth"},{"key":"39_CR143","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/ALN.0b013e31818ec946","volume":"110","author":"TT Horlocker","year":"2009","unstructured":"Horlocker TT, Burton AW, Connis RT et al (2009) Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology 110:218\u2013230","journal-title":"Anesthesiology"},{"key":"39_CR144","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.36076\/ppj.2011\/14\/E283","volume":"14","author":"TR Deer","year":"2011","unstructured":"Deer TR, Smith HS, Burton AW et al (2011) Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 14:E283\u2013E312","journal-title":"Pain Physician"},{"key":"39_CR145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/107327481402100208","volume":"21","author":"ID Papanastassiou","year":"2014","unstructured":"Papanastassiou ID, Filis AK, Gerochristou MA, Vrionis FD (2014) Controversial issues in kyphoplasty and vertebroplasty in malignant vertebral fractures. Cancer Control 21:151\u2013157","journal-title":"Cancer Control"}],"container-title":["International Manual of Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-21683-6_39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T05:04:05Z","timestamp":1675141445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-21683-6_39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319216829","9783319216836"],"references-count":145,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-21683-6_39","relation":{},"subject":[],"published":{"date-parts":[[2015]]}}}